Heng Xu

Regulatory network of GATA3 in pediatric acute lymphoblastic leukemia.

The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo.

The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing.

Rare gene variants in a patient with azathioprine-induced lethal myelosuppression.

TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.

Combination of common and novel rare variants improves predictive sensitivity of thiopurine-induced leukopenia in children with acute lymphoblastic leukemia.

Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer.

Induction and Amelioration of Methotrexate-Induced Gastrointestinal Toxicity are Related to Immune Response and Gut Microbiota.

Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences.

Structural and functional insights into the regulation of the lysis-lysogeny decision in viral communities.

Regulatory Network and Prognostic Effect Investigation of PIP4K2A in Leukemia and Solid Cancers.

Metabolism-induced tumor activator 1 (MITA1), an Energy Stress-Inducible Long Noncoding RNA, Promotes Hepatocellular Carcinoma Metastasis.

Prevotella copri is associated with carboplatin-induced gut toxicity.

Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models.

Cholesterol-modified DP7 enhances the effect of individualized cancer immunotherapy based on neoantigens.

The Role of ARID5B in Acute Lymphoblastic Leukemia and Beyond.

DP7-C-modified liposomes enhance immune responses and the antitumor effect of a neoantigen-based mRNA vaccine.

The Significance of the Fusion Gene in Gastric Cancer: A Systematic Review and Meta-Analysis.

Characterizing dedifferentiation of thyroid cancer by integrated analysis.

Genome-wide analysis identify novel germline genetic variations in influencing platinum-based chemotherapy response in non-small cell lung cancer.